◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
恩华药业 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 5.7B 5.0B 4.3B 3.9B 3.4B
Revenue Growth % 13.0% 17.3% 9.2% 17.1% --
Total Revenue 5.7B 5.0B 4.3B 3.9B 3.4B
Cost Of Revenue 1.5B 1.4B 1.0B 897.0M 822.0M
+Gross Profit 4.2B 3.7B 3.3B 3.0B 2.5B
Gross Margin % 73.6% 72.8% 76.3% 77.2% 75.5%
Total Operating Cost 4.5B 4.0B 3.4B 3.1B 2.6B
Selling Expenses 2.0B 1.7B 1.7B 1.6B 1.3B
Admin Expenses 259.0M 207.0M 193.0M 148.0M 133.0M
Rd Expenses 596.0M 549.0M 454.0M 352.0M 246.0M
Finance Expenses -17.1M -19.3M -20.8M -10.4M -24.0M
+Operating Income 1.3B 1.2B 1.0B 926.0M 856.0M
Operating Margin % 23.5% 23.4% 23.3% 23.5% 25.5%
Non Operating Income 4.7M 6.7M 2.5M 3.1M 933,900
Non Operating Expenses 44.5M 20.4M 16.1M 13.2M 6.6M
Investment Income 65.6M 51.0M 36.3M 36.2M 21.5M
Asset Disposal Income 294,000 147,200 373,500 -240,400 -148,800
Asset Impairment Loss 39.1M 33.3M 16.2M 35.3M 21.9M
Other Income 50.6M 50.0M 46.9M 32.7M 27.8M
Income Before Tax 1.3B 1.2B 990.0M 916.0M 850.0M
Income Tax 156.0M 134.0M 110.0M 118.0M 123.0M
+Net Income 1.1B 1.0B 880.0M 798.0M 727.0M
Net Margin % 20.0% 20.5% 20.5% 20.3% 21.6%
Net Income Attributable 1.1B 1.0B 901.0M 798.0M 729.0M
Minority Interest -2.8M -2.7M -20.6M 244,100 -1.7M
Eps Basic 1.13 1.03 0.89 0.79 0.72
Eps Diluted 1.13 1.03 0.89 0.79 0.72
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 1.4B 2.2B 1.5B 1.6B 1.4B
Trading Financial Assets 2.4B 1.3B 1.5B 1.1B 837.0M
Accounts Receivable 1.5B 1.0B 821.0M 677.0M 586.0M
Notes Receivable -- -- -- -- --
Notes And Accounts Receivable 1.5B 1.0B 821.0M 677.0M 586.0M
Prepayments 57.8M 36.6M 63.4M 20.0M 17.7M
Inventory 661.0M 629.0M 716.0M 604.0M 434.0M
Total Current Assets 6.1B 5.3B 4.7B 4.0B 3.3B
Long Term Equity Investment 97.3M 72.5M 78.4M 92.3M 39.0M
Fixed Assets -- 1.1B 1.1B 1.1B 1.0B
Fixed Assets Total 1.2B 1.1B 1.1B 1.1B 1.0B
Construction In Progress -- 294.0M 92.1M 17.2M 3.7M
Construction In Progress Total 309.0M 294.0M 92.1M 17.2M 3.7M
Intangible Assets 232.0M 190.0M 111.0M 96.0M 101.0M
Long Term Deferred Expenses 101.0M 42.3M 19.2M 9.0M 5.1M
Total Non Current Assets 2.4B 2.1B 1.8B 1.7B 1.4B
Total Assets 8.4B 7.3B 6.5B 5.7B 4.7B
Short Term Borrowings 15.0M 55.0M 30.0M 38.0M 38.0M
Accounts Payable 288.0M 216.0M 226.0M 243.0M 156.0M
Advance Receipts -- -- 34.1M -- --
Contract Liabilities 41.5M 26.5M 26.7M 24.1M 41.1M
Total Current Liabilities 1.1B 814.0M 794.0M 682.0M 575.0M
Long Term Borrowings 230,000 230,000 230,000 230,000 230,000
Total Non Current Liabilities 100.0M 104.0M 103.0M 111.0M 68.0M
Total Liabilities 1.2B 918.0M 897.0M 793.0M 643.0M
Paid In Capital 1.0B 1.0B 1.0B 1.0B 1.0B
Capital Reserve 244.0M 103.0M 119.0M 119.0M 49.8M
Surplus Reserve 508.0M 504.0M 504.0M 417.0M 332.0M
Retained Earnings 5.6B 4.8B 4.0B 3.4B 2.8B
Minority Equity -26.8M -24.0M -37.8M -17.0M -17.5M
Equity Attributable 7.3B 6.4B 5.6B 4.9B 4.1B
Total Equity 7.3B 6.4B 5.6B 4.9B 4.1B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 5.9B 5.3B 4.7B 4.2B 4.0B
Tax Refunds Received 253,400 21,100 288,200 862,500 766,300
Total Operating Cash Inflow 6.0B 5.4B 4.8B 4.2B 4.6B
Cash Paid For Goods 1.3B 1.1B 1.1B 805.0M 1.1B
Cash Paid To Employees 994.0M 940.0M 832.0M 751.0M 631.0M
Taxes Paid 738.0M 678.0M 543.0M 546.0M 471.0M
Total Operating Cash Outflow 5.1B 4.4B 3.9B 3.5B 3.3B
Operating Cash Flow 916.0M 1.0B 861.0M 701.0M 1.2B
Total Investing Cash Inflow 6.2B 6.5B 5.2B 3.7B 750.0M
Total Investing Cash Outflow 7.7B 6.8B 5.9B 4.1B 1.7B
Investing Cash Flow -1.4B -293.0M -689.0M -393.0M -912.0M
Cash From Borrowings 65.0M 80.0M 40.0M 38.0M 38.0M
Dividends And Interest Paid 324.0M 203.0M 203.0M 102.0M 104.0M
Debt Repayments 105.0M 55.0M 48.0M 38.0M 38.0M
Total Financing Cash Inflow 164.0M 80.0M 40.0M 38.0M 38.0M
Total Financing Cash Outflow 465.0M 290.0M 281.0M 165.0M 343.0M
Financing Cash Flow -301.0M -210.0M -241.0M -127.0M -305.0M
Net Change In Cash -796.0M 505.0M -67.7M 180.0M 30.9M
Ending Cash Balance 1.2B 2.0B 1.5B 1.6B 1.4B
Capex 450.0M 374.0M 328.0M 206.0M 269.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...